Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

Cited by (1,000)

Items 101–200 of 1,000

1. The role of glial cells in Parkinsonʼs disease
   Vila, Miquel, Jackson-Lewis, Vernice, Guégan, Christelle, Chu Wu, Du, Teismann, Peter, Choi, Dong-Kug, Tieu, Kim, Przedborski, Serge · 2001 · Current Opinion in Neurology
2. Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction
   Keigan M. Park, William J. Bowers · 2010 · Cellular Signalling
3. The 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine Mouse Model
   Serge Przedborski, Miquel Vila · 2003 · Annals of the New York Academy of Sciences
4. Lack of Nigral Pathology in Transgenic Mice Expressing Human α-Synuclein Driven by the Tyrosine Hydroxylase Promoter
   Matsuoka, Yasuji, Vila, Miquel, Lincoln, Sarah, McCormack, Alison, Picciano, Melanie, LaFrancois, John, Yu, Xin, Dickson, Dennis, Langston, William J., McGowan, Eileen et al. · 2001 · Neurobiology of Disease
5. The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer’s and Parkinson’s diseases1,2 11Guest Editors: Mark A. Smith and George Perry 22This article is part of a series of reviews on “Causes and Consequences of Oxidative Stress in Alzheimer’s Disease.” The full list of papers may be found on the homepage of the journal.
   Benoit I. Giasson, Harry Ischiropoulos, Virginia M.‐Y. Lee, John Q. Trojanowski · 2002 · Free Radical Biology and Medicine
6. Role of oxidative stress in paraquat‐induced dopaminergic cell degeneration
   Alison L. McCormack, Jennifer G. Atienza, Louisa C. Johnston, Julie Kay Andersen, Susan Vu, Donato A. Di Monte · 2005 · Journal of Neurochemistry
7. Pathogenic role of glial cells in Parkinson's disease
   Peter Teismann, Kim Tieu, Oren S. Cohen, Dong‐Kug Choi, Du Chu Wu, Daniel Marks, Miquel Vila, Vernice R. Jackson-Lewis, Serge Przedborski · 2002 · Movement Disorders
8. Microglial Activation and Dopaminergic Cell Injury: AnIn VitroModel Relevant to Parkinson's Disease
   Wei Dong Le, Dominic B. Rowe, Wenjie Xie, Irving Ortiz, Yi He, Stanley H. Appel · 2001 · Journal of Neuroscience
9. Inhibition of Calpains Prevents Neuronal and Behavioral Deficits in an MPTP Mouse Model of Parkinson's Disease
   Stephen J. Crocker, Patrice D. Smith, Vernice R. Jackson-Lewis, Wiplore R. Lamba, Shawn P. Hayley, Erich L. Grimm, Steve M. Callaghan, Ruth S. Slack, Edon Melloni, Serge Przedborski et al. · 2003 · Journal of Neuroscience
10. The role of Toll-like receptors and neuroinflammation in Parkinson’s disease
    Heidari, Arash, Yazdanpanah, Niloufar, Rezaei, Nima · 2022 · Journal of Neuroinflammation
11. Oxidative and Antioxidative Potential of Brain Microglial Cells
    Ralf Dringen · 2005 · Antioxidants and Redox Signaling
12. Role of Nitric Oxide Synthases in Parkinson’s Disease: A Review on the Antioxidant and Anti-inflammatory Activity of Polyphenols
    Katia Aquilano, Sara Baldelli, Giuseppe Rotilio, Maria Rosa Ciriolo · 2008 · Neurochemical Research
13. Nitric Oxide in Health and Disease of the Nervous System
    Andrew B. Knott, Ella Bossy‐Wetzel · 2008 · Antioxidants and Redox Signaling
14. Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function
    Steven W. Barger, Anthony S. Basile · 2001 · Journal of Neurochemistry
15. Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease
    Kim, Sehee, Moon, Minho, Park, Seungjoon · 2009 · Journal of Endocrinology
16. Parkin Deficiency Increases Vulnerability to Inflammation-Related Nigral Degeneration
    Tamy C. Frank-Cannon, Thi Anh Thu Tran, Kelly A. Ruhn, Terina N. Martinez, John J. Hong, Marian A. Marvin, Meagan Hartley, Isaac Treviño, Daniel E. O’Brien, Bradford H. Casey et al. · 2008 · Journal of Neuroscience
17. S-Nitrosylation-dependent Inactivation of Akt/Protein Kinase B in Insulin Resistance
    Takashi Yasukawa, Eriko Tokunaga, Hidetaka Ota, Hiroki Sugita, J. A. Jeevendra Martyn, Masao Kaneki · 2005 · Journal of Biological Chemistry
18. Microglia and neuroprotection: From in vitro studies to therapeutic applications
    Elisabetta Polazzi, Barbara Monti · 2010 · Progress in Neurobiology
19. Microglia: phagocyte and glia cell
    Frederik Vilhardt · 2004 · The International Journal of Biochemistry & Cell Biology
20. Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s Disease
    Zhang, Wei, Phillips, Kester, Wielgus, Albert R., Liu, Jie, Albertini, Alberto, Zucca, Fabio A., Faust, Rudolph, Qian, Steven Y., Miller, David S., Chignell, Colin F. et al. · 2011 · Neurotoxicity Research
21. T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?
    Appel, Stanley H., Beers, David R., Henkel, Jenny S. · 2010 · Trends in Immunology
22. Neurodegeneration by Activation of the Microglial Complement-Phagosome Pathway
    Bodea, L.-G., Wang, Y., Linnartz-Gerlach, B., Kopatz, J., Sinkkonen, L., Musgrove, R., Kaoma, T., Muller, A., Vallar, L., Di Monte, D. A. et al. · 2014 · Journal of Neuroscience
23. Microglia in the developing brain: a potential target with lifetime effects
    Harry, G. Jean, Kraft, Andrew D. · 2012 · NeuroToxicology
24. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti‐inflammatory action
    You‐Joung Kim, Hyun‐Jung Park, Gwang Lee, Oh Young Bang, Young Hwan Ahn, Eun-hye Joe, Hyun Ok Kim, Phil Hyu Lee · 2008 · Glia
25. Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration.
    Iravani, M.M, Kashefi, K, Mander, P, Rose, S, Jenner, P · 2002 · Neuroscience
26. Gene expression analysis in N‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R‐apomorphine
    Edna Grünblatt, Silvia A. Mandel, Gila Maor, Moussa B. H. Youdim · 2001 · Journal of Neurochemistry
27. Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor‐α
    Sriram, Krishnan, Miller, Diane B., O'Callaghan, James P. · 2006 · Journal of Neurochemistry
28. The interplay between iron accumulation, mitochondrial dysfunction, and inflammation during the execution step of neurodegenerative disorders
    Pamela J. Urrutia, Natalia P. Mena, Marco T. NÃoñez · 2014 · Frontiers in Pharmacology
29. Environmental Factors in Parkinson’s Disease
    Donato A. Di Monte, Mitra Lavasani, Amy Manning-Bog · 2002 · NeuroToxicology
30. Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease
    Amaicha Mara Depino, C. D. Earl, Elke Kaczmarczyk, Carina Cintia Ferrari, Hugo O. Besedovsky, Adriana del Rey, Fernando Juan Pitossi, Wolfgang Hermann Oertel · 2003 · European Journal of Neuroscience
31. Neuroimmunological Processes in Parkinson’s Disease and their Relation to α-Synuclein: Microglia as the Referee between Neuronal Processes and Peripheral Immunity
    Vanesa Sánchez-Guajardo, Christopher J. Barnum, Malú G. Tansey, Marina Romero‐Ramos · 2013 · ASN NEURO
32. Microglia in the CNS: Immigrants from another world
    Marco Prinz, Alexander Mildner · 2010 · Glia
33. The Role of Sex and Sex Hormones in Neurodegenerative Diseases
    Elisabetta Vegeto, Alessandro Maria Villa, Sara Della Torre, V. Crippa, P. Rusmini, Riccardo Cristofani, M. Galbiati, Adriana C. Maggi, Angelo Poletti · 2019 · Endocrine Reviews
34. WIN55,212‐2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson’s disease
    David A. Price, Alex Anthony Martinez, Alexandre Seillier, Wouter Koek, Yolanda P. Villarreal Acosta, Elizabeth Fernández, Randy Strong, Beat Lutz, Giovanni Marsicano, James L. Roberts et al. · 2009 · European Journal of Neuroscience
35. Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism
    Ros-Bernal, Francisco, Hunot, Stéphane, Herrero, Maria Trinidad, Parnadeau, Sebastien, Corvol, Jean-Christophe, Lu, Lixia, Alvarez-Fischer, Daniel, Carrillo-de Sauvage, María Angeles, Saurini, Françoise, Coussieu, Christiane et al. · 2011 · Proceedings of the National Academy of Sciences
36. Jmjd3 is essential for the epigenetic modulation of microglia phenotypes in the immune pathogenesis of Parkinson’s disease
    Yu Tang, Tengda Li, Junyi Li, Juan Yang, Haiqing Liu, Xiao-Xuan Zhang, Weidong Le · 2013 · Cell Death and Differentiation
37. GAPDH as a sensor of NO stress
    Makoto R. Hara, Matthew B. Cascio, Akira Sawa · 2006 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
38. Poly(ADP‐ribose) polymerase‐1 activity promotes NF‐κB‐driven transcription and microglial activation: implication for neurodegenerative disorders
    Alberto Chiarugi, Michael A. Moskowitz · 2003 · Journal of Neurochemistry
39. Ulcerative colitis exacerbates lipopolysaccharide‐induced damage to the nigral dopaminergic system: potential risk factor in Parkinson`s disease
    Ruth F. Villarán, Ana M. Espinosa‐Oliva, Manuel Sarmiento Soto, Rocío M. de Pablos, Sandro Argüelles, María José Delgado‐Cortés, Verónica Sobrino, Nico van Rooijen, Jose Luis Venero, Antonio J. Herrera et al. · 2010 · Journal of Neurochemistry
40. NMDA But Not Non-NMDA Excitotoxicity is Mediated by Poly(ADP-Ribose) Polymerase
    Allen S. Mandir, Marc F. Poitras, Adam R. Berliner, William Joseph Herring, Daniel B. Guastella, Alicia B. Feldman, Guy G. Poirier, Zhao‐Qi Wang, Ted M. Dawson, Valina Lynn Dawson · 2000 · Journal of Neuroscience
41. Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS
    Jannette Rodríguez‐Pallares, Pablo Rey, Juan A. Parga, Ana Muñoz, María J. Guerra, José Luis Labandeira-García · 2008 · Neurobiology of Disease
42. Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson's disease
    Yolanda Gómez‐Gálvez, Cristina Palomo‐Garo, Javier Fernández‐Ruíz, Concepción García · 2015 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
43. Neuroprotective Effect of Ghrelin in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson’s Disease by Blocking Microglial Activation
    Moon, Minho, Kim, Hyo Geun, Hwang, Lakkyong, Seo, Ji-Hyung, Kim, Sehee, Hwang, Sunyoung, Kim, Soonyong, Lee, Dahm, Chung, Hyunju, Oh, Myung Sook et al. · 2009 · Neurotoxicity Research
44. Toxicological and pathophysiological roles of reactive oxygen and nitrogen species
    Ruth Angela Roberts, Robert Anthony Smith, Stephen H Safe, Csaba Szabó, Ronald B. Tjalkens, Fredika M. Robertson · 2010 · Toxicology
45. Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism
    Veronica Francardo, Francesco Bez, Tadeusz W. Wieloch, Hans Nissbrandt, Karsten Ruscher, Maria Angela Cenci · 2014 · Brain
46. Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure
    Carlos Barcia, Angel Sánchez-Bahíllo, Emiliano Fernández‐Villalba, Víctor Bautista‐Hernández, M. Poza, A Fernández-Barreiro, Étienne C. Hirsch, María Trinidad Herrero · 2004 · Glia
47. Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase
    Wei Zhang, Tongguang Wang, Liya Qin, Hui‐Ming Gao, Belinda C. Wilson, Syed F. Ali, Wanqin Zhang, Jau‐Shyong Hong, Bin Liu · 2004 · The FASEB Journal
48. Oxidative and nitrative protein modifications in Parkinson's disease
    Steven R. Danielson, Julie Kay Andersen · 2008 · Free Radical Biology and Medicine
49. Impaired Inflammatory Responses in Murine Lrrk2-Knockdown Brain Microglia
    Beomsue Kim, Myung-Soon Yang, Dong‐Joo Choi, Jong-Hyeon Kim, Hye-Sun Kim, Wongi Seol, Sangdun Choi, Ilo Jou, Eun-Young Kim, Eun-hye Joe · 2012 · PLoS ONE
50. Hydrogen in Drinking Water Reduces Dopaminergic Neuronal Loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mouse Model of Parkinson's Disease
    Kyota Fujita, Toshihiro Seike, Noriko Yutsudo, Mizuki Ohno, Hidetaka Yamada, Hiroo Yamaguchi, Kunihiko Sakumi, Yukiko Yamakawa, Mizuho A. Kido, Atsushi Takaki et al. · 2009 · PLoS ONE
51. Reactive Oxygen and Nitrogen Species: Weapons of Neuronal Destruction in Models of Parkinson's Disease
    Serge Przedborski, Harry Ischiropoulos · 2005 · Antioxidants and Redox Signaling
52. Chronic Stress Enhances Microglia Activation and Exacerbates Death of Nigral Dopaminergic Neurons under Conditions of Inflammation
    de Pablos, Rocío M, Herrera, Antonio J, Espinosa-Oliva, Ana M, Sarmiento, Manuel, Muñoz, Mario F, Machado, Alberto, Venero, José L · 2014 · Journal of Neuroinflammation
53. Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-α, interleukin-1β, and nitric oxide
    Dave A. Gayle, Zaodung Ling, Chong Wai Tong, Teresa M. Landers, Jack W. Lipton, Paul M. Carvey · 2002 · Developmental Brain Research
54. S100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway
    Sathe, Kinnari, Maetzler, Walter, Lang, Johannes D., Mounsey, Ross B., Fleckenstein, Corina, Martin, Heather L., Schulte, Claudia, Mustafa, Sarah, Synofzik, Matthis, Vukovic, Zvonimir et al. · 2012 · Brain
55. Caffeine protects against MPTP‐induced blood‐brain barrier dysfunction in mouse striatum
    Chen, Xuesong, Lan, Xun, Roche, Ian, Liu, Rugao, Geiger, Jonathan D. · 2008 · Journal of Neurochemistry
56. MPTP: a review of its mechanisms of neurotoxicity
    Serge Przedborski, Miquel Vila · 2001 · Clinical Neuroscience Research
57. The inflammatory response in the MPTP model of Parkinson’s disease is mediated by brain angiotensin: relevance to progression of the disease
    Belen Joglar, Jannette Rodríguez‐Pallares, Ana Isabel Rodriguez-Perez, Pablo Rey, María J. Guerra, José Luis Labandeira-García · 2009 · Journal of Neurochemistry
58. Macrophage Delivery of Therapeutic Nanozymes in A Murine Model of Parkinson‘S Disease
    Anna M. Brynskikh, Yuling Zhao, Rodney Lee Mosley, Shu Li, Michael D. Boska, Natalia L. Klyachko, Alexander V. Kabanov, Howard Eliot Gendelman, Elena V. Batrakova · 2010 · Nanomedicine
59. Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration.
    T. Arimoto, G. Bing · 2003 · Neurobiology of Disease
60. Cell death: protein misfolding and neurodegenerative diseases
    Tomohiro Nakamura, Stuart A. Lipton · 2009 · APOPTOSIS
61. A review of the mechanisms of cone degeneration in retinitis pigmentosa
    Daniel S. Narayan, John P. M. Wood, Glyn Chidlow, Robert James Casson · 2016 · Acta Ophthalmologica
62. Optical and pharmacological tools to investigate the role of mitochondria during oxidative stress and neurodegeneration
    Kelley A. Foster, Francesca Galeffi, Florian J. Gerich, Dennis A. Turner, Michael Müller · 2006 · Progress in Neurobiology
63. Genetic ablation of tumor necrosis factor‐alpha (TNF‐α) and pharmacological inhibition of TNF‐synthesis attenuates MPTP toxicity in mouse striatum
    Boris Ferger, Andreas Leng, Anna Mura, Bastian Hengerer, Joram Feldon · 2004 · Journal of Neurochemistry
64. Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer’s disease, in APP23 transgenic mice and after experimental brain lesion in rat: Evidence for an induction by amyloid pathology
    Lüth, Hans-Joachim, Holzer, Max, Gärtner, Ulrich, Staufenbiel, Matthias, Arendt, Thomas · 2001 · Brain Research
65. Mucuna pruriens reduces inducible nitric oxide synthase expression in Parkinsonian mice model
    Satyndra Kumar Yadav, Sachchida Nand, Surya Pratap Singh · 2016 · Journal of Chemical Neuroanatomy
66. Role of nitric oxide in Parkinson's disease
    Li Zhang, Valina Lynn Dawson, Ted M. Dawson · 2005 · Pharmacology & Therapeutics
67. Neuroprotective Effects of Resveratrol on MPTP-Induced Neuron Loss Mediated by Free Radical Scavenging
    Kwok‐Tung Lu, Meng-Chang Ko, Bo-Yu Chen, Ji-Chuu Huang, Chia‐Wen Hsieh, Ming-Chung Lee, Robin Y.‐Y. Chiou, Being‐Sun Wung, Cheng-Hsiung Peng, Yi-Ling Yang · 2008 · Journal of Agricultural and Food Chemistry
68. COX‐2 and Neurodegeneration in Parkinson's Disease
    Peter Teismann, Miquel Vila, Dong‐Kug Choi, Kim Tieu, Du-Chu Wu, Vernice R. Jackson-Lewis, Serge Przedborski · 2003 · Annals of the New York Academy of Sciences
69. Lewy Body Pathology in Alzheimer's Disease
    Kotzbauer, Paul T., Tojanowski, John Q., Lee, Virginia M. V. · 2001 · Journal of Molecular Neuroscience
70. Antioxidant gene therapy against neuronal cell death
    Juliana Navarro-Yepes, Laura Mireya Zavala-Flores, Annadurai Anandhan, Fang Wang, Maciej Skotak, Namas Chandra, Ming Li, Aglaia Pappa, Daniel Martínez‐Fong, Luz María Del Razo et al. · 2013 · Pharmacology & Therapeutics
71. Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress
    Mohammed Danish Akbar, Musthafa Mohamed Essa, Ghazi Daradkeh, Mohamed A. Abdelmegeed, Youngshim Choi, Lubna Mahmood, Byoung‐Joon Song · 2016 · Brain Research
72. Peroxynitrite and Mitochondrial Dysfunction in the Pathogenesis of Parkinson's Disease
    Manuchair Ebadi, Sushil Kumar Sharma · 2003 · Antioxidants and Redox Signaling
73. Simvastatin Inhibits the Activation of p21rasand Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson's Disease
    Anamitra Ghosh, Avik Roy, Joanna Matras, Saurav Brahmachari, Howard Eliot Gendelman, Kalipada Pahan · 2009 · Journal of Neuroscience
74. Nitric Oxide–GAPDH–Siah: A Novel Cell Death Cascade
    Makoto R. Hara, Solomon H. Snyder · 2006 · Cellular and Molecular Neurobiology
75. Neuroinflammation in Parkinson’s Disease
    Jae‐Kyung Lee, Thi Anh Thu Tran, Malú G. Tansey · 2009 · Journal of Neuroimmune Pharmacology
76. Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair
    Vivekanantham, Sayinthen, Shah, Savan, Dewji, Rizwan, Dewji, Abbas, Khatri, Chetan, Ologunde, Rele · 2015 · International Journal of Neuroscience
77. Neuroprotective Effects of the Triterpenoid, CDDO Methyl Amide, a Potent Inducer of Nrf2-Mediated Transcription
    Lichuan Yang, Noel Ylagan Calingasan, Bobby Thomas, Rajnish Kumar Chaturvedi, Mahmoud Kiaei, Elizabeth J. Wille, Karen T. Liby, Charlotte R. Williams, Darlene B. Royce, Renee Risingsong et al. · 2009 · PLoS ONE
78. Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington's disease
    Crapser, Joshua D, Ochaba, Joseph, Soni, Neelakshi, Reidling, Jack C, Thompson, Leslie M, Green, Kim N · 2020 · Brain
79. Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia
    Giia-Sheun Peng, Guorong Li, Nian‐Sheng Tzeng, Po-See Chen, De‐Maw Chuang, Yaw‐Don Hsu, Sufen Yang, Jau‐Shyong Hong · 2004 · Molecular Brain Research
80. Role of nitric oxide in the regulation of neuronal proliferation, survival and differentiation
    Antonio Contestabile, Elisabetta Ciani · 2004 · Neurochemistry International
81. Redox cycling of the herbicide paraquat in microglial cultures
    Dafna Bonneh‐Barkay, Stephen H. Reaney, J. William Langston, Donato A. Di Monte · 2005 · Molecular Brain Research
82. Differential effect of nitric oxide on glutathione metabolism and mitochondrial function in astrocytes and neurones: implications for neuroprotection/neurodegeneration?
    Matthew E. Gegg, Belén Beltrán, Silvia Salas-Pino, Juan Pedro Bolaños, J. B. Clark, Salvador Moncada, Simon Heales · 2003 · Journal of Neurochemistry
83. The role of inflammation in sporadic and familial Parkinson’s disease
    Michela Deleidi, Thomas Gasser · 2013 · Cellular and Molecular Life Sciences
84. Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation
    Mario Delgado, Doina Ganea · 2003 · The FASEB Journal
85. Novel tactics for neuroprotection in Parkinson's disease: role of antibiotics, polyphenols and neuropeptides
    Reglodi, Dora, Renaud, Justine, Tamas, Andrea, Tizabi, Yousef, Socías, Sergio B., Del-Bel, Elaine, Raisman-Vozari, Rita · 2017 · Progress in Neurobiology
86. Aberrant protein S-nitrosylation contributes to the pathophysiology of neurodegenerative diseases
    Nakamura, Tomohiro, Prikhodko, Olga A., Pirie, Elaine, Nagar, Saumya, Akhtar, Mohd Waseem, Oh, Chang-Ki, McKercher, Scott R., Ambasudhan, Rajesh, Okamoto, Shu-ichi, Lipton, Stuart A. · 2015 · Neurobiology of Disease
87. Thrombin-Induced Microglial Activation Produces Degeneration of Nigral Dopaminergic NeuronsIn Vivo
    Sang-H. Choi, Eun H. Joe, Seung Up Kim, Byung Kwan Jin · 2003 · Journal of Neuroscience
88. The role of nitric oxide in brain disorders: Autism spectrum disorder and other psychiatric, neurological, and neurodegenerative disorders
    Manish Kumar Tripathi, Maryam Kartawy, Haitham Amal · 2020 · Redox Biology
89. Metabolic Dysfunction in Parkinson’s Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism
    Annadurai Anandhan, Maria S. Jacome, Shulei Lei, Pablo Hernández-Franco, Aglaia Pappa, Mihalis I. Panayiotidis, Robert Powers, Rodrigo Franco · 2017 · Brain Research Bulletin
90. Oxidative Stress and Microglial Cells in Parkinson's Disease
    Lynda J. Peterson, Patrick M. Flood · 2012 · Mediators of Inflammation
91. Paroxetine Prevents Loss of Nigrostriatal Dopaminergic Neurons by Inhibiting Brain Inflammation and Oxidative Stress in an Experimental Model of Parkinson’s Disease
    Young Cheul Chung, Sang Ryong Kim, Byung Kwan Jin · 2010 · The Journal of Immunology
92. Adenosine A2A receptor antagonists exert motor and neuroprotective effects by distinct cellular mechanisms
    Liqun Yu, Hai‐Ying Shen, Joana Esteves Coelho, Inês M. Araújo, Qingyuan Huang, Yuan‐Ji Day, Nelson Rebola, Paula M. Canas, Erica Kirsten Rapp, Jarrod Ferrara et al. · 2008 · Annals of Neurology
93. Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra
    Z.-H Feng, T.-G Wang, D.-D Li, P. C. W. Fung, Belinda C. Wilson, Bin Liu, Syed F. Ali, Robert J. Langenbach, Jau‐Shyong Hong · 2002 · Neuroscience Letters
94. Mitochondria and Programmed Cell Death in Parkinson's Disease: Apoptosis and Beyond
    Céline Perier, Jordi Bové, Miquel Vila · 2011 · Antioxidants and Redox Signaling
95. Genetic deletion or pharmacological inhibition of cyclooxygenase‐1 attenuate lipopolysaccharide‐ induced inflammatory response and brain injury
    Sangho Choi, Robert I. Langenbach, Francesca Bosetti · 2007 · The FASEB Journal
96. Microglia activation states and cannabinoid system: Therapeutic implications
    Míriam Mecha, Francisco Javier Carrillo-Salinas, Ana Feliú, Leyre Mestre, Carmen Guaza · 2016 · Pharmacology & Therapeutics
97. Minocycline Enhances MPTP Toxicity to Dopaminergic Neurons
    Yang, Lichuan, Sugama, Shuei, Chirichigno, Jason W., Gregorio, Jason, Lorenzl, Stefan, Shin, Dong H., Browne, Susan E., Shimizu, Yoshinori, Joh, Tong H., Beal, M. Flint et al. · 2003 · Journal of Neuroscience Research
98. Thioredoxin and Thioredoxin Reductase in Relation to Reversible S -Nitrosylation
    Sengupta, Rajib, Holmgren, Arne · 2013 · Antioxidants & Redox Signaling
99. Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients
    Hua She, Qian Yang, Kennie Raviie Shepherd, Yoland Smith, Gary W. Miller, Claudia M. Testa, Zixu Mao · 2011 · Journal of Clinical Investigation
100. Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury
     A. Sauerbeck, Jian-Xin Gao, Ryan D. Readnower, Mei Liu, J. Pauly, G. Bing, P. Sullivan · 2010 · Experimental Neurology